Refine by
Infection Treatment Articles & Analysis
84 news found
The Centers for Disease Control and Prevention (CDC) reports there are an estimated 450,000 cases of shigellosis, an infection caused by Shigella bacteria, in the United States each year. ...
As antibiotic resistance continues to pose a global health threat, Profacgen is expanding its services to assist researchers, pharmaceutical companies, and healthcare providers in developing new antimicrobial agents that could shape the future of infectious disease treatment. Antimicrobial peptides (AMPs) are small, naturally occurring molecules that exhibit potent activity ...
These mouse models can facilitate comprehensive research into the pathogenesis, immune response, and efficacy of antiviral treatments against influenza A infections. Influenza A viruses are members of the Orthomyxoviridae family with a unique genome consisting of eight single-stranded negative-sense RNA fragments. ...
Despite progress, an effective animal model that mimics human immune response during HIV/TB co-infection has been lacking, hindering treatment and vaccine development. Bohorguez et al. (2024) developed a humanized NSG-SGM3 mouse model to advance HIV/TB co-infection studies. These mice are transplanted with human CD34+ stem cells, enabling the ...
Culture is the gold standard for diagnosis of adenovirus infection. However, culture results can take up to 3 weeks. Serological tests have a faster turnaround time but may not be as sensitive as culture. Because of the clinical importance of rapid laboratory diagnosis, direct detection of viral antigens in nasopharyngeal secretions, feces, or both is used as the primary ...
Daptomycin is an essential antibiotic used in the treatment of serious bacterial infections, including skin and bloodstream infections. With its potent bactericidal activity against Gram-positive pathogens, Daptomycin has been a crucial treatment option for healthcare professionals around the world. Daptomycin ReadyMade™ ...
Hao Yang, President of China Association for STD and AIDS Prevention and Treatment; Mrs. Wang Xinlun, Vice President and Secretary-General of China Association for STD and AIDS Prevention and Treatment, industry experts and representatives of partner companies and institutions attended the ceremony. Since China initiated antiretroviral treatment ...
Funding from the BARDA Division of Research, Innovation, and Ventures (DRIVe) enabled the company to reformulate LMN-301, previously developed for oral delivery, and to evaluate its potential as an anti-viral therapeutic delivered to the respiratory tract, the primary site of SARS-CoV-2 infection. The efficacy of the intranasal formulation was evaluated by collaborators at the ...
Most patients are sent home the same day following their treatment, and they can resume normal activities in less than 24 hours. ...
"FDA provided clear guidance and considered the program outlined by MerLion for the development of finafloxacin towards potential licensure for the treatment of infections caused by Burkholderia pseudomallei - for both a naturally occurring and biodefense-related melioidosis indication - feasible," said Dr. ...
To discover the more advantages of VelaShape body slimming machine, talk to a friendly member of our team. Velashape cellulite treatment can help improve the look and feel of skin. What is VelaShape treatment? ...
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi Ondine’s nonantibiotic photodisinfection technology has been proven in Canadian hospitals to kill pathogens helping to generate 84% reduction of postoperative infection ...
Frontier Biotechnologies announced that the Azerbaijan Republic Ministry of Health approved Aikening® (Albuvirtide), the first long-acting intravenous infusion for the treatment of HIV-1 infection in adults. Aikening® is a new fusion inhibitor given once weekly, used in combination dual therapy to treat people living with HIV who have failed initial ...
The LIAISON MeMed BV test is the first fully automated solution, which utilizes host response-based data to enable physicians to differentiate accurately between bacterial and viral infections, supporting fast and better-informed treatment and patient management decisions. ...
ByMeMed
In the positive, Phase 2, proof-of-concept CHARMS treatment study in allo-HCT patients, more than 90% of patients who did not respond to or could not tolerate conventional treatment had a complete or partial clinical response after receiving posoleucel. ...
ByKalaris
The funding project is titled “Pravibismane Suspension as a Topical, Broad Spectrum Anti-Infective Wound Care Treatment and Prevention for Combat Injury-Related Infections”. ...
(CCHCI) today announced a collaboration with The Body Agency Collective (TBAC) and Visby Medical, Inc., to improve sexually transmitted infection (STI) diagnosis and treatment in observance of National STD Awareness Week. ...
Her experience also includes nine years with GlaxoSmithKline (GSK) in senior medical leadership roles including, Vice President of Medical Excellence and Quality, Vice President and Global Head, Infectious Diseases Medicines Development Center, as well as Vice President of Stiefel Laboratories, GSK's dermatology franchise focusing on acne treatments and ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of ...
All patients demonstrated a statistically significant reduction in the rate of all-cause hospitalizations and severe infections, relative to pre-treatment. Evidence of resolution of LAD-I-related skin rash and restoration of wound repair capabilities has been shown along with sustained phenotypic correction. ...